Alaunos Therapeutics, Inc. Depreciation
Alaunos Therapeutics, Inc. (TCRT) reported Depreciation of $17.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- Alaunos Therapeutics, Inc. depreciation for the quarter ending 2026-06-30 was $9.00K.
- Alaunos Therapeutics, Inc. depreciation for the quarter ending 2026-03-31 was $8.00K.
- Alaunos Therapeutics, Inc. depreciation for the quarter ending 2025-12-31 was $7.00K.
- Alaunos Therapeutics, Inc. depreciation for the quarter ending 2025-09-30 was $0.00.
- Alaunos Therapeutics, Inc. depreciation for fiscal 2025 was $7.00K, a 250.00% increase from fiscal 2024.
- Alaunos Therapeutics, Inc. depreciation for fiscal 2024 was $2.00K, a 99.91% decline from fiscal 2023.
- Alaunos Therapeutics, Inc. depreciation for fiscal 2023 was $2.31M, a 16.09% decline from fiscal 2022.
- Alaunos Therapeutics, Inc. depreciation for fiscal 2022 was $2.76M, a 6.24% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $17.00K 10-Q · filed 2026-08-14 | $24.00K derived: sum of 3 quarters · filed 2026-08-14 | $24.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $8.00K 10-Q · filed 2026-05-15 | $15.00K derived: sum of 2 quarters · filed 2026-05-15 | $15.00K derived: sum of 3 quarters · filed 2026-05-15 | $15.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $7.00K derived: sum of 2 quarters · filed 2026-03-31 | $7.00K derived: sum of 3 quarters · filed 2026-08-14 | $7.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $0.00 10-Q · filed 2025-11-14 | -$1.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | -$1.00K derived: sum of 3 quarters · filed 2026-08-14 | -$1.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | -$1.00K derived: sum of 2 quarters · filed 2026-05-15 | -$1.00K derived: sum of 3 quarters · filed 2026-05-15 | $0.00 derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.00K derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | $2.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.00K derived: sum of 2 quarters · filed 2025-11-14 | $3.00K 10-Q · filed 2025-11-14 | $244.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $3.00K 10-Q · filed 2025-08-14 | $244.00K derived: sum of 3 quarters · filed 2025-08-14 | $923.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $2.00K 10-Q · filed 2024-05-15 | $243.00K derived: sum of 2 quarters · filed 2025-03-31 | $922.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.62M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-12-31 | $241.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $920.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.62M derived: sum of 3 quarters · filed 2025-03-31 | $2.31M 10-K · filed 2025-03-31 |
| 2023-09-30 | $679.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.38M derived: sum of 2 quarters · filed 2024-11-14 | $2.07M 10-Q · filed 2024-11-14 | $2.77M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $699.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.40M 10-Q · filed 2024-08-14 | $2.09M derived: sum of 3 quarters · filed 2024-08-14 | $2.78M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $696.00K 10-Q · filed 2024-05-15 | $1.39M derived: sum of 2 quarters · filed 2024-05-15 | $2.08M derived: sum of 3 quarters · filed 2024-05-15 | $2.77M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $694.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.39M derived: sum of 2 quarters · filed 2024-04-01 | $2.07M derived: sum of 3 quarters · filed 2024-04-01 | $2.76M 10-K · filed 2024-04-01 |
| 2022-09-30 | $691.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.38M derived: sum of 2 quarters · filed 2023-11-14 | $2.06M 10-Q · filed 2023-11-14 | $2.77M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $685.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.37M 10-Q · filed 2023-08-14 | $2.08M derived: sum of 3 quarters · filed 2023-08-14 | $2.75M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $689.00K 10-Q · filed 2023-05-10 | $1.39M derived: sum of 2 quarters · filed 2023-05-10 | $2.07M derived: sum of 3 quarters · filed 2023-05-10 | $2.75M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $705.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $1.38M derived: sum of 2 quarters · filed 2023-03-07 | $2.06M derived: sum of 3 quarters · filed 2023-03-07 | $2.60M 10-K · filed 2023-03-07 |
| 2021-09-30 | $673.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.35M derived: sum of 2 quarters · filed 2022-11-14 | $1.89M 10-Q · filed 2022-11-14 | $2.31M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $679.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.22M 10-Q · filed 2022-08-15 | $1.64M derived: sum of 3 quarters · filed 2022-08-15 | $1.96M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $540.00K 10-Q · filed 2022-05-16 | $960.00K derived: sum of 2 quarters · filed 2022-05-16 | $1.28M derived: sum of 3 quarters · filed 2022-05-16 | $1.53M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $420.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $738.00K derived: sum of 2 quarters · filed 2022-03-30 | $986.00K derived: sum of 3 quarters · filed 2022-03-30 | $1.13M 10-K · filed 2022-03-30 |
| 2020-09-30 | $318.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $566.00K derived: sum of 2 quarters · filed 2021-11-08 | $708.00K 10-Q · filed 2021-11-08 | $884.00K derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $248.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $390.00K 10-Q · filed 2021-08-13 | $566.00K derived: sum of 3 quarters · filed 2021-08-13 | $723.00K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $142.00K 10-Q · filed 2021-05-06 | $318.00K derived: sum of 2 quarters · filed 2021-05-06 | $475.00K derived: sum of 3 quarters · filed 2021-05-06 | $631.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $333.00K derived: sum of 2 quarters · filed 2021-03-01 | $489.00K derived: sum of 3 quarters · filed 2021-03-01 | $629.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $313.00K derived: sum of 2 quarters · filed 2020-11-05 | $453.00K 10-Q · filed 2020-11-05 | $616.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $156.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $296.00K 10-Q · filed 2020-08-06 | $459.00K derived: sum of 3 quarters · filed 2021-03-01 | $616.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $140.00K 10-Q · filed 2020-05-07 | $303.00K derived: sum of 2 quarters · filed 2021-03-01 | $460.00K derived: sum of 3 quarters · filed 2021-03-01 | $598.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $320.00K derived: sum of 2 quarters · filed 2021-03-01 | $458.00K derived: sum of 3 quarters · filed 2021-03-01 | $575.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $295.00K derived: sum of 2 quarters · filed 2019-11-07 | $412.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $255.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $117.00K 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $369.00K 10-K · filed 2020-03-02 | |||
| 2016-12-31 | $290.00K 10-K · filed 2019-03-05 | |||
| 2015-12-31 | $357.00K 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |